- Successfully developed new antibodies for use in breast cancer
research & therapy:
--experimented with antigen preparation and immunization routines,
resulting in the desired immune response;
--carefully monitored the antisera to ensure presence of desired
B-cell population;
--tailored screening strategies using ELISA, RIA and immunoblot
techniques, to effectively isolate the desired hybridomas.
- Developed, in collaboration with others, a novel assay which
identifies the antibodies' ability to bind to live, intact tumor
cells.
- Delivered periodic presentations of results and works in
progress, to staff of Cancer Research Institute.
|